Chemed (NYSE:CHE) EVP Spencer Lee Sells 920 Shares of Company Stock

Posted by Brian Himes on Nov 4th, 2026

Chemed Corporation (NYSE:CHE – Get Free Report) EVP Spencer Lee sold 920 shares of the business’s stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $537.17, for a total value of $494,196.40. Following the completion of the sale, the executive vice president owned 13,931 shares in the company, valued at approximately $7,483,315.27. This trade represents a 6.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Chemed Stock Down 1.5%

NYSE:CHE opened at $534.10 on Wednesday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.08 and a current ratio of 1.11. The company has a market cap of $6.95 billion, a PE ratio of 23.67, a PEG ratio of 2.06 and a beta of 0.50. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $562.24. The stock has a 50-day simple moving average of $514.53 and a 200 day simple moving average of $463.84.

Chemed (NYSE:CHE – Get Free Report) last announced its earnings results on Tuesday, October 27th. The company reported $6.75 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.44 by $0.31. The business had revenue of $690.94 million for the quarter, compared to analyst estimates of $685.04 million. Chemed had a return on equity of 35.18% and a net margin of 10.61%. Chemed’s revenue for the quarter was up 10.6% compared to the same quarter last year. During the same quarter last year, the firm earned $5.27 EPS. On average, sell-side analysts expect that Chemed Corporation will post 24.05 EPS for the current fiscal year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th were issued a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. This is a boost from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date was Monday, August 17th. Chemed’s dividend payout ratio is 13.40%.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Ethic Inc. lifted its position in shares of Chemed by 20.0% in the third quarter. Ethic Inc. now owns 1,343 shares of the company’s stock valued at $678,000 after buying an additional 224 shares during the last quarter. Palisade Asset Management LLC acquired a new position in shares of Chemed during the 3rd quarter worth approximately $269,000. Parallel Advisors LLC increased its holdings in shares of Chemed by 10.8% during the 3rd quarter. Parallel Advisors LLC now owns 596 shares of the company’s stock worth $301,000 after acquiring an additional 58 shares during the last quarter. United Advisor Group LLC raised its stake in Chemed by 7.0% in the 3rd quarter. United Advisor Group LLC now owns 1,554 shares of the company’s stock valued at $785,000 after acquiring an additional 102 shares during the period. Finally, Kestra Advisory Services LLC raised its stake in Chemed by 115.9% in the 3rd quarter. Kestra Advisory Services LLC now owns 3,273 shares of the company’s stock valued at $1,653,000 after acquiring an additional 1,757 shares during the period. 95.85% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

CHE has been the subject of several recent research reports. Wall Street Zen upgraded shares of Chemed from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 10th. Jefferies Financial Group raised shares of Chemed from a “hold” rating to a “buy” rating and raised their target price for the company from $520.00 to $620.00 in a research report on Wednesday, October 28th. Weiss Ratings upgraded shares of Chemed from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. Bank of America reissued a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Finally, Oppenheimer increased their price objective on shares of Chemed from $590.00 to $625.00 and gave the stock an “outperform” rating in a research note on Thursday, October 29th. Three equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $603.00.

Get Our Latest Stock Analysis on Chemed

Chemed Company Profile

(Get Free Report)

Chemed Corporation (NYSE:CHE) is a Cincinnati, Ohio-based company that provides healthcare and residential and commercial services through two operating businesses: VITAS Healthcare and Roto-Rooter. Its operations serve customers primarily in the United States, with Roto-Rooter also providing services in Canada.

VITAS Healthcare is a provider of hospice and palliative care for individuals with advanced illnesses. The business delivers care in patients’ homes, hospice inpatient units, hospitals, nursing facilities and other care settings.